Clinical trial
The Assessment of Health Literacy, Rational Drug Use, and Cyberchondria Levels in Individuals With Inflammatory Rheumatic Diseases
NCT06993935 is registered in ClinicalTrials.gov with Gulseren Demir Karakilic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Assessment of Health Literacy, Rational Drug Use, and Cyberchondria Levels in Individuals With Inflammatory Rheumatic Diseases
- Lead sponsor
- Gulseren Demir Karakilic
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 6, 2026
- Completion date
- July 24, 2026
- Enrollment
- 228 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic disease, cyberchondria, health literacy, inflammatory arthritis, rational drug use, rheumatoid arthritis